Target intelligence / Profile preview

Hematopoiesis promotion via multi-herbal synergy

Molecular classification
Other (refers to biological process/modulation, not a molecule/receptor)
01

Overview

Hematopoiesis promotion via multi-herbal synergy refers to the therapeutic strategy of using combinations of herbal medicines to enhance or restore blood cell formation, particularly in the context of myelosuppression (e.g., post-chemotherapy), anemia, or immune dysfunction. This approach relies on the multitarget and multipathway actions of phytochemicals in various herbs, which may act additively or synergistically, affecting cellular signaling pathways, growth factor production, immune modulation, and protection against hematopoietic damage[1][2][3]. There is no single molecular entity or therapeutic target by this name; it is a systems pharmacology concept reflecting an integrative therapeutic approach rather than a druggable macromolecule.

02

Mechanism of action

Synergistic modulation of signaling pathways involved in hematopoiesis, such as PI3K-Akt, MAPK, IL-17, TNF, FoxO, HIF-1, NF-κB, p53. Upregulation of hematopoietic growth factors (e.g., G-CSF, GM-CSF). Protection against immune-mediated myelosuppression. Regulation of immune response and cytokine networks. Modulation of bile acid metabolism and biotin synthesis pathways (for some formulas).

03

Biological functions

Hematopoiesis regulationCell proliferation (of hematopoietic stem/progenitor cells)Immune modulationCytoprotection (e.g., reducing myelosuppression)
04

Disease associations

Hematological disorders (e.g., myelosuppression, anemia)Cancer therapy-induced cytopeniasImmune dysfunction or immunosuppression
05

Safety considerations

Variability of herbal composition and dosingRisk of herb-drug interactions (especially in oncology patients)Quality control of multi-herbal productsUnknown long-term toxicity profiles for some formulations
06

Interacting drugs

Samul-tang (consisting of Angelicae Gigantis Radix, Rehmanniae Radix Preparata, Paeoniae Radix Alba, and Cnidii Rhizoma)

2 more in the full profile.

07

Biomarkers

G-CSF (granulocyte-colony stimulating factor)GM-CSF (granulocyte-macrophage colony-stimulating factor)general hematologic parameters (e.g., bone marrow counts, immune cell profiles)

Beyond the preview

Go deeper on Hematopoiesis promotion via multi-herbal synergy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematopoiesis promotion via multi-herbal synergy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call